|
ANTX AN2 Therapeutics Inc 1880438 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-8,185,000.00 |
| Balance Sheet |
|
Current Assets
|
$79,991,000.00 |
|
Assets
|
$81,676,000.00 |
|
Current Liabilities
|
$5,585,000.00 |
|
Liabilities
|
$5,755,000.00 |
|
Equity
|
$75,921,000.00 |
|
Shares Out
|
36308669.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-19,071,000.00 |
|
Investing Cash Flow
|
$4,630,000.00 |
| Market Analysis |
Market Cap
|
$210,227,193.51 |
|
Price
|
$5.79 |
|
BVPS
|
2.09 |
|
PB
|
2.77 |
|
EPS
|
-0.18 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:38 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANTX documents filed with the SEC.
ANTX Filings
Clear
